Cov19VaxKB: COVID-19 Vaccine Knowledgebase

COVID-19 Vaccine Safety

This site is dedicated for the safety issues related to COVID-19 vaccines.

The following is a list of news related to COVID-19 vaccines:

12/11/2020: Sanofi and GSK announce a delay in their adjuvanted recombinant protein-based COVID-19 vaccine program to improve immune response in the elderly
12/11/2020: University of Queensland and CSL announce that they will not proceed with Phase II and III clinical trials of their COVID-19 vaccine
11/11/2020: Phase 3 trial of Sinovac’s COVID-19 vaccine in Brazil resumes after brief pause due to suicide of a study subject
10/23/2020: Johnson & Johnson prepares to resume Phase 3 Trial of its Janssen COVID-19 Vaccine Candidate in the U.S.
10/23/2020: FDA authorizes restart of the US Phase III trial of the AZD1222 vaccine
10/21/2020: Volunteer in placebo group of AZD1222 Phase III trial in Brazil dies, trial continues
10/12/2020: Johnson & Johnson pauses Phase III trial of Ad26COVS1 vaccine
10/2/2020: Phase III trial of AZD1222 vaccine in Japan resumes after pause, following restart of trials in the UK, Brazil, South Africa, and India
9/28/2020: Phase II/III trial of INO-4800 vaccine placed on partial clinical hold due to FDA concerns
9/15/2020: Phase III trial of AZD1222 vaccine in Brazil and South Africa resumes after pause
9/12/2020: Phase III trial of AZD1222 vaccine in the UK resumes after pause
9/9/2020: Clinical trials of AZD1222 vaccine placed on hold in the UK, USA, Brazil, and South Africa due to “adverse event” in a clinical trial subject

Provenance: All data in Cov19VaxKB originates from manual curation of reliable resources

Note: The page was updated at December 14, 2020. We plan to update this page on a weekly or even a daily basis. Please provide us with any new information that you believe would be useful if included on the website.